Safety and side-effects of buprenorphine in the clinical management of heroin addiction.
about
Update on the clinical use of buprenorphine: in opioid-related disordersUtilizing buprenorphine-naloxone to treat illicit and prescription-opioid dependencePractical considerations for the clinical use of buprenorphine.Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience.Buprenorphine: a (relatively) new treatment for opioid dependence.Opioid dependence treatment, including buprenorphine/naloxone.Buprenorphine tapering schedule and illicit opioid use.Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in human placenta by liquid chromatography mass spectrometry.Short-term safety of buprenorphine/naloxone in HIV-seronegative opioid-dependent Chinese and Thai drug injectors enrolled in HIV Prevention Trials Network 058.Combating opiate dependence: a comparison among the available pharmacological options.Home buprenorphine/naloxone induction in primary careHeroin detoxification with buprenorphine on an inpatient psychiatric unitDevelopment and validation of a liquid chromatography-tandem mass spectrometry assay for the simultaneous quantification of buprenorphine, norbuprenorphine, and metabolites in human urine.Validation and application of a method for the determination of buprenorphine, norbuprenorphine, and their glucuronide conjugates in human meconiumIntersection of chronic pain treatment and opioid analgesic misuse: causes, treatments, and policy strategies.Effects of HCV seropositive status on buprenorphine pharmacokinetics in opioid-dependent individuals.Comorbid pain and opioid addiction: psychosocial and pharmacological treatments.Hepatic Safety of Buprenorphine in HIV-Infected and Uninfected Patients With Opioid Use Disorder: The Role of HCV-Infection.Management of opioid addiction with buprenorphine: French history and current management.Substitution pharmacotherapies for opioid addiction: from methadone to LAAM and buprenorphine.Opioid-abusing health care professionals: options for treatment and returning to work after treatment.A comparison of four buprenorphine dosing regimens in the treatment of opioid dependence.Mise à jour sur l’utilisation clinique de la buprénorphine: pour les troubles reliés aux opioïdes.The clinical use of buprenorphine in opiate addiction: evidence and practice.Naloxone-induced withdrawal in patients with buprenorphine dependence.
P2860
Q26829140-EA6CABDC-C266-4E4F-AD55-23B8D3DEF824Q26865674-630F596D-F011-44BC-A66E-A88A94014A8AQ33774853-CFD78219-4A95-43CC-8DC3-04D45BDF70D0Q34081656-2709C781-3D5D-46C4-9B84-D787C071FF74Q34365302-D06391F5-E10A-4054-8B63-E0C1A4FC8283Q34533873-0E20B51F-7796-4C2A-9D0A-30267125EAA5Q35147170-A6D310E7-DAC5-45B2-BAD4-776DFF914F7CQ35175087-77D0EC44-76A2-4259-A109-2BC99C2EA94BQ35608547-A164D590-48B2-4D85-A4AF-E971B42DE6A4Q35753371-05388826-95BF-4001-9745-7F72A322757AQ37067770-BDCC3846-8F18-4064-97CC-2E8B0828CA50Q37079337-38FFCAF6-43E9-4439-AC7F-8D080BB729E7Q37161397-76CDF573-9A37-44EB-8BBF-5EB3212DDA45Q37210263-2C7B8156-CE75-42A0-92A2-8614F5660ABBQ37355278-035ED036-F40B-49F9-BDDA-31BFA37A8674Q37721776-AFAC00EC-6B00-40DC-8C4A-7339E2CC96AFQ37901021-73721046-BBDE-4BDF-A62F-BA2625DD88F0Q38901411-225895B0-6DA9-44C3-907F-454C678BD9A9Q40177170-5FE574D0-58AC-467C-A316-92874F555F2FQ40635730-2D265985-7ACE-4D97-9A1D-1D872BC1322BQ42335834-76CA87AA-9019-44DE-A436-E4589563086BQ44352899-084D7B31-7D2A-4EB4-B2E8-018D2080CD75Q45847009-5309EDF2-B4B4-499D-AE45-1A45393A357AQ51936969-86DA57E2-76EC-4F70-A03C-FB612F27680DQ52272873-ED1FF61B-07EE-4D09-BE90-80DB11043548
P2860
Safety and side-effects of buprenorphine in the clinical management of heroin addiction.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
Safety and side-effects of buprenorphine in the clinical management of heroin addiction.
@en
Safety and side-effects of buprenorphine in the clinical management of heroin addiction.
@nl
type
label
Safety and side-effects of buprenorphine in the clinical management of heroin addiction.
@en
Safety and side-effects of buprenorphine in the clinical management of heroin addiction.
@nl
prefLabel
Safety and side-effects of buprenorphine in the clinical management of heroin addiction.
@en
Safety and side-effects of buprenorphine in the clinical management of heroin addiction.
@nl
P2093
P1476
Safety and side-effects of buprenorphine in the clinical management of heroin addiction.
@en
P2093
P356
10.1016/0376-8716(90)90078-S
P577
1990-08-01T00:00:00Z